299 filings
Page 5 of 15
6-K
ut0rurrnqgfbj
12 Jul 21
Enlivex Initiates Design and Construction Process for a New cGMP Allocetra Manufacturing Plant
8:00am
6-K
qarjpbcq
15 Jun 21
Report of Foreign Private Issuer
7:55am
S-8
zm4 2hh1s
4 Jun 21
Registration of securities for employees
4:16pm
6-K
f74spku1 sn6on
1 Jun 21
Enlivex Announces Issuance of New Canadian Patent Covering Pharmaceutical Compositions, Manufacturing Methods and Uses of Allocetra Immunotherapy
8:02am
6-K
ku4wxulk989eikcf
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
27b5lu7
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am
6-K
xr8ah0kjwjy9gqe1kl0
22 Mar 21
Report of Foreign Private Issuer
8:02am
6-K
vl97ek kmu41n
8 Mar 21
Enlivex Receives Notice of Allowance for Japanese Patent Application
8:03am
6-K
2kehpck 9cdt1y15
1 Mar 21
Report of Foreign Private Issuer
7:58am
6-K
ya7cw0c 4bsgf
22 Feb 21
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering Allocetra Immunotherapy
8:04am
6-K
rdyp5p2g2lyhf72pbl7
18 Feb 21
Enlivex Announces Exercise of Underwriter’s Option to Purchase Additional Shares
8:03am
6-K
j6nkf3
16 Feb 21
Current report (foreign)
8:30am
6-K
s9p g49hv
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
73qts
10 Feb 21
Prospectus supplement for primary offering
5:22pm
FWP
53b62tqyoi5extlwv
10 Feb 21
Free writing prospectus
6:08am
F-3MEF
bi4i9u8d
9 Feb 21
Registration statement to add securities to prior F-3 registration
9:40pm
FWP
hetm2d
9 Feb 21
Free writing prospectus
5:21pm
424B5
vcbv3jy4 cc2flbgr2
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
t1sdxk12bcel5la rvx
9 Feb 21
Report of Foreign Private Issuer
4:41pm